Deutsche Bank AG Purchases 157,334 Shares of Sotera Health Company $SHC

Key Points

• Deutsche Bank AG increased its holdings in Sotera Health Company by 1,902.2%, acquiring an additional 157,334 shares and totaling 165,605 shares worth approximately $1.93 million.
• Sotera Health reported a quarterly EPS of $0.20, beating estimates, and had revenues of $294.34 million, marking a 6.4% increase from the previous year.
• Equities research analysts have issued a consensus rating of "Moderate Buy" for Sotera Health, with Goldman Sachs upgrading their price target from $14.00 to $17.00.

Deutsche Bank AG boosted its holdings in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 1,902.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 165,605 shares of the company's stock after acquiring an additional 157,334 shares during the quarter. Deutsche Bank AG owned 0.06% of Sotera Health worth $1,931,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of SHC. Charles Schwab Investment Management Inc. raised its position in shares of Sotera Health by 5.1% during the first quarter. Charles Schwab Investment Management Inc. now owns 1,415,282 shares of the company's stock worth $16,502,000 after acquiring an additional 68,087 shares during the last quarter. XTX Topco Ltd acquired a new position in shares of Sotera Health in the first quarter worth approximately $602,000. Victory Capital Management Inc. lifted its stake in shares of Sotera Health by 5.7% in the first quarter. Victory Capital Management Inc. now owns 57,655 shares of the company's stock worth $672,000 after acquiring an additional 3,106 shares during the period. Principal Financial Group Inc. lifted its stake in shares of Sotera Health by 0.3% in the first quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock worth $4,109,000 after acquiring an additional 1,037 shares during the period. Finally, Teacher Retirement System of Texas acquired a new position in shares of Sotera Health in the first quarter worth approximately $266,000. Institutional investors own 91.03% of the company's stock.

Sotera Health Stock Up 3.1%

Shares of SHC traded up $0.50 during trading hours on Friday, reaching $16.43. The stock had a trading volume of 1,302,737 shares, compared to its average volume of 1,654,382. The company has a market capitalization of $4.67 billion, a price-to-earnings ratio of 205.40 and a beta of 1.81. The firm has a 50-day simple moving average of $12.35 and a 200 day simple moving average of $12.16. The company has a current ratio of 2.47, a quick ratio of 2.23 and a debt-to-equity ratio of 4.49. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.08.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, topping the consensus estimate of $0.17 by $0.03. The firm had revenue of $294.34 million for the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a net margin of 2.14% and a return on equity of 39.42%. The business's revenue was up 6.4% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.19 earnings per share. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Equities research analysts predict that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Analyst Ratings Changes

SHC has been the subject of several research analyst reports. Barclays reissued an "overweight" rating on shares of Sotera Health in a research report on Friday, August 8th. The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and lifted their price objective for the stock from $14.00 to $17.00 in a research report on Monday, May 5th. Finally, Wall Street Zen raised Sotera Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 16th. Four investment analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, Sotera Health presently has an average rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Company Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.